• OPEN AN ACCOUNT
Indian Indices
Nifty
25,112.40 319.15
(1.29%)
Sensex
82,408.17 1,046.30
( 1.29%)
Bank Nifty
56,252.85 675.40
( 1.22%)
Nifty IT
38,991.45 326.50
( 0.84%)
Global Indices
Nasdaq
42,197.27 -39.54
(-0.09%)
Dow Jones
6,001.75 -1.97
(-0.03%)
Hang Seng
38,498.24 9.90
(0.03%)
Nikkei 225
8,774.65 -17.15
(-0.20%)
Forex
USD-INR
86.44 0.19
(0.22%)
EUR-INR
99.39 -0.08
(-0.08%)
GBP-INR
116.19 -0.40
(-0.35%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Parenteral Drugs (India) Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524689
INE904D01019
-300.6045095
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PDPL
0
10.11
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Sanmit Infra standalone net profit rises 194.44% in the March 2025 quarter
May 29,2025
Net profit of Sanmit Infra rose 194.44% to Rs 1.59 crore in the quarter ended March 2025 as against Rs 0.54 crore during the previous quarter ended March 2024. Sales rose 103.02% to Rs 45.03 crore in the quarter ended March 2025 as against Rs 22.18 crore during the previous quarter ended March 2024.

For the full year,net profit declined 65.10% to Rs 1.56 crore in the year ended March 2025 as against Rs 4.47 crore during the previous year ended March 2024. Sales rose 51.73% to Rs 142.96 crore in the year ended March 2025 as against Rs 94.22 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales45.0322.18 103 142.9694.22 52
OPM %6.647.17 -4.099.52 -
PBDT2.911.33 119 5.047.97 -37
PBT2.190.59 271 2.266.06 -63
NP1.590.54 194 1.564.47 -65